NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
19.85
+0.89 (4.69%)
At close: Jul 3, 2025, 1:00 PM
19.86
+0.01 (0.05%)
After-hours: Jul 3, 2025, 3:40 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Transformative Therapies for Cardio-metabolic Diseases
45.56M
Log In
Log In
Transformative Therapies for Cardio-metabolic Diseases Growth
223.37%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Italy
45.56M
Log In
Log In
Italy Growth
223.37%
Log In
Log In